Global survey reveals top workforce concerns, evolving strategic priorities, and key technology investment areas for life sciences manufacturers
The samples of both products mentioned in the CDSCO list are spurious and not manufactured by Alkem
At 24 months, data from the Phase 1 exPDite trial continue to show a favorable safety profile in all 12 participants in the trial’s high and low dose cohorts
NMC to continue its efforts to improve and enhance the quality of medical education in the country
Eugia Steriles receives EIR from USFDA for new injectable facility
KEYTRUDA is the first and only immunotherapy-based regimen to show a statistically significant and clinically meaningful improvement in overall survival
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
The acquisition is based on an enterprise value of Rs. 1,660 crore
ALS patients experience neuroinflammation and rapid neurodegeneration
This case is an isolated case, similar to the earlier 30 cases reported in India from July 2022 onwards
Subscribe To Our Newsletter & Stay Updated
